Theralogix
Theralogix was founded in 2002 by a team of physicians and scientists committed to developing evidence-based, independently certified micronutrient supplements.
Since that time, under the guidance of an Advisory Board of nationally-recognized experts in male and female fertility, we have developed a suite of products which provide reproductive and hormonal health solutions for both men and women.
Every Theralogix product undergoes independent, third-party verification of content and purity through the ANSI 173 Dietary Supplement Certification Program at NSF® International, a non-profit agency in Ann Arbor, Michigan.
Multiple Theralogix products have been chosen for use in university-sponsored and NIH-funded clinical trials that are currently underway.
Theralogix products, including TheraNatal®, Ovavite®, Ovasitol® and ConceptionXR® are currently used by clinics responsible for more than half the ART cycles in the U.S. From pre-conception to nursing, Theralogix reproductive health products have become the choice of thousands of healthcare providers and their patients.
CoQ10 and Female Fertility and Live Q&A with Dr. Mark Ratner
CoQ10 and Female Fertility
In this lecture, Dr Mark Ratner discusses -Understanding aneuploidy and egg quality, CoQ10 and energy production, CoQ10: treatment basics
Dr. Mark Ratner is the founder and Chief Science Officer of Theralogix. A practicing physician for more than 30 years, he pursued his undergraduate studies and a Master’s degree program in Nutrition at Cornell University. His medical school and graduate medical training were completed at Tulane University School of Medicine. Dr. Ratner previously served as the Director of Male Reproductive Medicine at Shady Grove Fertility Center in Washington, DC. He has served as an investigator for numerous drug development trials, and currently coordinates product development at Theralogix. In addition, he oversees the use of Theralogix products in several NIH-funded, university-based clinical trials.
Insulin Resistance and PCOS- The Expanding Role of Inositols
Insulin Resistance and PCOS- The Expanding Role of Inositols: Live Q&A with Dr. Mark Ratner
Insulin resistance plays an important role in the metabolic and reproductive effects of PCOS. This webinar explores the pathophysiology of PCOS, the underlying mechanism of insulin resistance in PCOS, and the clinical studies which confirm the ability of inositol’s to correct both metabolic and reproductive PCOS endpoint.
Dr. Mark Ratner is the founder and Chief Science Officer of Theralogix. A practicing physician for more than 30 years, he pursued his undergraduate studies and a Master’s degree program in Nutrition at Cornell University. His medical school and graduate medical training were completed at Tulane University School of Medicine. Dr. Ratner previously served as the Director of Male Reproductive Medicine at Shady Grove Fertility Center in Washington, DC. He has served as an investigator for numerous drug development trials, and currently coordinates product development at Theralogix. In addition, he oversees the use of Theralogix products in several NIH-funded, university-based clinical trials.